{"id":48529,"date":"2026-08-28T10:02:01","date_gmt":"2026-08-28T10:02:01","guid":{"rendered":"https:\/\/conseil-concurrence.ma\/communique-du-conseil-de-la-concurrence-relatif-au-projet-de-concentration-economique-concernant-la-prise-par-la-societe-cfao-healthcare-sa-du-controle-exclusif-de-la-societe-meab\/"},"modified":"2026-08-31T10:25:23","modified_gmt":"2026-08-31T10:25:23","slug":"press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c","status":"publish","type":"post","link":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/","title":{"rendered":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d."},"content":{"rendered":"<p>In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the transaction\u201d below, containing the information provided by the parties.<\/p>\n<p>This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed transaction.<\/p>\n<p>The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n<p><strong>Names of the companies and groups involved:<\/strong><\/p>\n<ul>\n<li><strong>The acquirer: \u201c<\/strong>CFAO Healthcare SA\u201d;<\/li>\n<li><strong>The target: <\/strong>\u201cMeaban Maroc SARL\u201d.<\/li>\n<\/ul>\n<p><strong>Nature of the transaction:<\/strong><\/p>\n<ul>\n<li>Acquisition of exclusive control.<\/li>\n<\/ul>\n<p><strong>Economic sectors concerned:<\/strong><\/p>\n<ul>\n<li>The sector of promotion, marketing, and communication services.<\/li>\n<\/ul>\n<p><strong>Deadline for interested third parties to submit their observations:<\/strong><\/p>\n<ul>\n<li>10 days from the date of publication of this press release, i.e. September 9, 2026.<\/li>\n<\/ul>\n<p><strong>NON-CONFIDENTIAL SUMMARY OF THE TRANSACTION PROVIDED BY THE PARTIES<\/strong><\/p>\n<p>The Competition Council received notification of an economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d, through the acquisition of 100% of its share capital and associated voting rights.<\/p>\n<p><strong>\u201cCFAO Healthcare SA\u201d <\/strong>is a French public limited company with a share capital of \u20ac2,799,750, registered with the Nanterre Trade and Companies Register under number 307 718 577 and headquartered at 57-59, rue Yves Kermen, 92100 Boulogne-Billancourt (France). The company \u201cCFAO Healthcare SA\u201d belongs to the \u201cCFAO\u201d group. This company is active in the manufacture, distribution, and marketing of pharmaceutical and medical products as well as in the provision of associated services.<\/p>\n<p><strong>\u201cMeaban Maroc SARL\u201d <\/strong>is a Moroccan limited liability company with a capital of 52,209,000 dirhams, registered with the Casablanca Trade Register under number 97789 and headquartered at No. 106, rue Abderrahmane Sahraoui, Casablanca.<br \/>\n\u201cMeaban Maroc SARL\u201d is active in the field of promotion, marketing, and communication services for players in the pharmaceutical, parapharmaceutical, and cosmetic industries.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\">Done in Rabat on August 28, 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the transaction\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed transaction. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups involved: The acquirer: \u201cCFAO Healthcare SA\u201d; The target: \u201cMeaban Maroc SARL\u201d. Nature of the transaction: Acquisition of exclusive control. Economic sectors concerned: The sector of promotion, marketing, and communication services. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e. September 9, 2026. NON-CONFIDENTIAL SUMMARY OF THE TRANSACTION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d, through the acquisition of 100% of its share capital and associated voting rights. \u201cCFAO Healthcare SA\u201d is a French public limited company with a share capital of \u20ac2,799,750, registered with the Nanterre Trade and Companies Register under number 307 718 577 and headquartered at 57-59, rue Yves Kermen, 92100 Boulogne-Billancourt (France). The company \u201cCFAO Healthcare SA\u201d belongs to the \u201cCFAO\u201d group. This company is active in the manufacture, distribution, and marketing of pharmaceutical and medical products as well as in the provision of associated services. \u201cMeaban Maroc SARL\u201d is a Moroccan limited liability company with a capital of 52,209,000 dirhams, registered with the Casablanca Trade Register under number 97789 and headquartered at No. 106, rue Abderrahmane Sahraoui, Casablanca. \u201cMeaban Maroc SARL\u201d is active in the field of promotion, marketing, and communication services for players in the pharmaceutical, parapharmaceutical, and cosmetic industries. &nbsp; Done in Rabat on August 28, 2026.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-48529","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc\" \/>\n<meta property=\"og:description\" content=\"In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the transaction\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed transaction. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups involved: The acquirer: \u201cCFAO Healthcare SA\u201d; The target: \u201cMeaban Maroc SARL\u201d. Nature of the transaction: Acquisition of exclusive control. Economic sectors concerned: The sector of promotion, marketing, and communication services. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e. September 9, 2026. NON-CONFIDENTIAL SUMMARY OF THE TRANSACTION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d, through the acquisition of 100% of its share capital and associated voting rights. \u201cCFAO Healthcare SA\u201d is a French public limited company with a share capital of \u20ac2,799,750, registered with the Nanterre Trade and Companies Register under number 307 718 577 and headquartered at 57-59, rue Yves Kermen, 92100 Boulogne-Billancourt (France). The company \u201cCFAO Healthcare SA\u201d belongs to the \u201cCFAO\u201d group. This company is active in the manufacture, distribution, and marketing of pharmaceutical and medical products as well as in the provision of associated services. \u201cMeaban Maroc SARL\u201d is a Moroccan limited liability company with a capital of 52,209,000 dirhams, registered with the Casablanca Trade Register under number 97789 and headquartered at No. 106, rue Abderrahmane Sahraoui, Casablanca. \u201cMeaban Maroc SARL\u201d is active in the field of promotion, marketing, and communication services for players in the pharmaceutical, parapharmaceutical, and cosmetic industries. &nbsp; Done in Rabat on August 28, 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Conseil de la concurrence du Maroc\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T10:02:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-31T10:25:23+00:00\" \/>\n<meta name=\"author\" content=\"Youssef OTMANE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Youssef OTMANE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/\"},\"author\":{\"name\":\"Youssef OTMANE\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/03683379dc5edfcb3044e506a05bdf1b\"},\"headline\":\"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d.\",\"datePublished\":\"2026-08-28T10:02:01+00:00\",\"dateModified\":\"2026-08-31T10:25:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/\"},\"wordCount\":391,\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/\",\"name\":\"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\"},\"datePublished\":\"2026-08-28T10:02:01+00:00\",\"dateModified\":\"2026-08-31T10:25:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/03683379dc5edfcb3044e506a05bdf1b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/\",\"name\":\"Conseil de la concurrence du Maroc\",\"description\":\"Conseil de la concurrence\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/#\\\/schema\\\/person\\\/03683379dc5edfcb3044e506a05bdf1b\",\"name\":\"Youssef OTMANE\",\"url\":\"https:\\\/\\\/conseil-concurrence.ma\\\/en\\\/author\\\/youssef\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/","og_locale":"en_US","og_type":"article","og_title":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc","og_description":"In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201csummary of the transaction\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council&#8217;s position on the proposed transaction. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of the companies and groups involved: The acquirer: \u201cCFAO Healthcare SA\u201d; The target: \u201cMeaban Maroc SARL\u201d. Nature of the transaction: Acquisition of exclusive control. Economic sectors concerned: The sector of promotion, marketing, and communication services. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e. September 9, 2026. NON-CONFIDENTIAL SUMMARY OF THE TRANSACTION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d, through the acquisition of 100% of its share capital and associated voting rights. \u201cCFAO Healthcare SA\u201d is a French public limited company with a share capital of \u20ac2,799,750, registered with the Nanterre Trade and Companies Register under number 307 718 577 and headquartered at 57-59, rue Yves Kermen, 92100 Boulogne-Billancourt (France). The company \u201cCFAO Healthcare SA\u201d belongs to the \u201cCFAO\u201d group. This company is active in the manufacture, distribution, and marketing of pharmaceutical and medical products as well as in the provision of associated services. \u201cMeaban Maroc SARL\u201d is a Moroccan limited liability company with a capital of 52,209,000 dirhams, registered with the Casablanca Trade Register under number 97789 and headquartered at No. 106, rue Abderrahmane Sahraoui, Casablanca. \u201cMeaban Maroc SARL\u201d is active in the field of promotion, marketing, and communication services for players in the pharmaceutical, parapharmaceutical, and cosmetic industries. &nbsp; Done in Rabat on August 28, 2026.","og_url":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/","og_site_name":"Conseil de la concurrence du Maroc","article_published_time":"2026-08-28T10:02:01+00:00","article_modified_time":"2026-08-31T10:25:23+00:00","author":"Youssef OTMANE","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Youssef OTMANE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/#article","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/"},"author":{"name":"Youssef OTMANE","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/03683379dc5edfcb3044e506a05bdf1b"},"headline":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d.","datePublished":"2026-08-28T10:02:01+00:00","dateModified":"2026-08-31T10:25:23+00:00","mainEntityOfPage":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/"},"wordCount":391,"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/","url":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/","name":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d. - Conseil de la concurrence du Maroc","isPartOf":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#website"},"datePublished":"2026-08-28T10:02:01+00:00","dateModified":"2026-08-31T10:25:23+00:00","author":{"@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/03683379dc5edfcb3044e506a05bdf1b"},"breadcrumb":{"@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/conseil-concurrence.ma\/en\/press-release-from-the-competition-council-regarding-the-economic-concentration-project-concerning-the-acquisition-by-the-company-cfao-healthcare-sa-of-the-exclusive-control-of-the-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/conseil-concurrence.ma\/en\/"},{"@type":"ListItem","position":2,"name":"Press release from the Competition Council regarding the economic concentration project concerning the acquisition by the company \u201cCFAO Healthcare SA\u201d of the exclusive control of the company \u201cMeaban Maroc SARL\u201d."}]},{"@type":"WebSite","@id":"https:\/\/conseil-concurrence.ma\/en\/#website","url":"https:\/\/conseil-concurrence.ma\/en\/","name":"Conseil de la concurrence du Maroc","description":"Conseil de la concurrence","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/conseil-concurrence.ma\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/conseil-concurrence.ma\/en\/#\/schema\/person\/03683379dc5edfcb3044e506a05bdf1b","name":"Youssef OTMANE","url":"https:\/\/conseil-concurrence.ma\/en\/author\/youssef\/"}]}},"_links":{"self":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/48529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/comments?post=48529"}],"version-history":[{"count":1,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/48529\/revisions"}],"predecessor-version":[{"id":48530,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/posts\/48529\/revisions\/48530"}],"wp:attachment":[{"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/media?parent=48529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/categories?post=48529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conseil-concurrence.ma\/en\/wp-json\/wp\/v2\/tags?post=48529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}